Home
About Us
The Company
Leadership
Board of Directors
Scientific Advisory Board
Contact Us
Our Science
Pan-RAS Program
PDE10/β-catenin Program
Pipeline
Overview
Small Molecule Pan-RAS Inhibitors
Small Molecule PDE10/β-catenin Inhibitors
Investors
Investor Relations
Presentations and Events
Press Releases
SEC Company Filings
Selected Publications
Home
About Us
The Company
Leadership
Board of Directors
Scientific Advisory Board
Contact Us
Our Science
Pan-RAS Program
PDE10/β-catenin Program
Pipeline
Overview
Small Molecule Pan-RAS Inhibitors
Small Molecule PDE10/β-catenin Inhibitors
Investors
Investor Relations
Presentations and Events
Press Releases
SEC Company Filings
Selected Publications
TARGETED APPROACHES
TO FIGHTING CANCER
FOCUSED ON SCIENCE
COMMITTED
TO PATIENTS
We are Anchiano Therapeutics, a biopharmaceutical company dedicated to the discovery, development, and commercialization of novel targeted therapies to treat cancer.
